BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21885601)

  • 21. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
    Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance.
    Turbyville JC; Rao VK
    Autoimmun Rev; 2010 May; 9(7):488-93. PubMed ID: 20170754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
    Dowdell KC; Niemela JE; Price S; Davis J; Hornung RL; Oliveira JB; Puck JM; Jaffe ES; Pittaluga S; Cohen JI; Fleisher TA; Rao VK
    Blood; 2010 Jun; 115(25):5164-9. PubMed ID: 20360470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
    Shah S; Wu E; Rao VK; Tarrant TK
    Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
    Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
    J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmune lymphoproliferative syndrome: a case report].
    Youssif HB; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Maani KE; Bousfiha AA
    Pan Afr Med J; 2022; 43():61. PubMed ID: 36523284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
    Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
    Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
    Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
    Front Immunol; 2018; 9():2400. PubMed ID: 30386345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
    Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
    Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis.
    Rudman Spergel A; Walkovich K; Price S; Niemela JE; Wright D; Fleisher TA; Rao VK
    Pediatrics; 2013 Nov; 132(5):e1440-4. PubMed ID: 24101757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
    Cayrol J; Garrido Colino C
    J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
    Teachey DT
    Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome].
    Molnár E; Kovács G; Varga L; Tasnády S; Bors A; Tankó L; Csabán D; Kapócs K; Nemes-Nagy Z; Andrikovics H
    Orv Hetil; 2022 Jan; 163(4):123-131. PubMed ID: 35066491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications.
    Batlle-Masó L; Garcia-Prat M; Parra-Martínez A; Franco-Jarava C; Aguiló-Cucurull A; Velasco P; Antolín M; Rivière JG; Martín-Nalda A; Soler-Palacín P; Martínez-Gallo M; Colobran R
    Front Immunol; 2022; 13():1014984. PubMed ID: 36466883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome.
    Dekeyser C; Naesens L; Offner F; De Vriendt C; Schauwvlieghe A; Kerre T; Laureys G
    J Neuroimmunol; 2022 Jun; 367():577866. PubMed ID: 35453041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
    Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
    J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
    Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
    J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study.
    Hägele P; Staus P; Scheible R; Uhlmann A; Heeg M; Klemann C; Maccari ME; Ritterbusch H; Armstrong M; Cutcutache I; Elliott KS; von Bernuth H; Leahy TR; Leyh J; Holzinger D; Lehmberg K; Svec P; Masjosthusmann K; Hambleton S; Jakob M; Sparber-Sauer M; Kager L; Puzik A; Wolkewitz M; Lorenz MR; Schwarz K; Speckmann C; Rensing-Ehl A; Ehl S;
    Lancet Haematol; 2024 Feb; 11(2):e114-e126. PubMed ID: 38302222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.